203 related articles for article (PubMed ID: 25803537)
1. Sputum glucose and glycemic control in cystic fibrosis-related diabetes: a cross-sectional study.
Van Sambeek L; Cowley ES; Newman DK; Kato R
PLoS One; 2015; 10(3):e0119938. PubMed ID: 25803537
[TBL] [Abstract][Full Text] [Related]
2. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
3. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
[TBL] [Abstract][Full Text] [Related]
4. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
5. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study.
Pincikova T; Nilsson K; Moen IE; Fluge G; Hollsing A; Knudsen PK; Lindblad A; Mared L; Pressler T; Hjelte L;
Diabetologia; 2011 Dec; 54(12):3007-15. PubMed ID: 21901282
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control and FEV
Okoniewski W; Hughan KS; Weiner GA; Weiner DJ; Forno E
J Cyst Fibros; 2020 May; 19(3):460-465. PubMed ID: 31980357
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis.
Nielsen BU; Kolpen M; Jensen PØ; Katzenstein T; Pressler T; Ritz C; Mathiesen IHM; Faurholt-Jepsen D
PLoS One; 2020; 15(9):e0238524. PubMed ID: 32915806
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch IB
Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
11. [Continuous glucose monitoring system in the screening of glucose disorders in cystic fibrosis].
Martín-Frías M; Lamas Ferreiro A; Colino Alcol E; Alvarez Gómez MA; Yelmo Valverde R; Barrio Castellanos R
An Pediatr (Barc); 2009 Feb; 70(2):120-5. PubMed ID: 19217566
[TBL] [Abstract][Full Text] [Related]
12. Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!
Bergenstal RM
Diabetes Care; 2015 Aug; 38(8):1615-21. PubMed ID: 26207055
[TBL] [Abstract][Full Text] [Related]
13. Conventional measures underestimate glycaemia in cystic fibrosis patients.
Dobson L; Sheldon CD; Hattersley AT
Diabet Med; 2004 Jul; 21(7):691-6. PubMed ID: 15209760
[TBL] [Abstract][Full Text] [Related]
14. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
15. Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis.
Piva TC; Luft C; Antunes KH; Marostica PJC; Pinto LA; Donadio MVF
Respir Med; 2020 Oct; 172():106144. PubMed ID: 32937222
[TBL] [Abstract][Full Text] [Related]
16. [Carbohydrate metabolic changes in cystic fibrosis].
García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
[TBL] [Abstract][Full Text] [Related]
17. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
[TBL] [Abstract][Full Text] [Related]
19. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.
Selvin E; Coresh J; Golden SH; Brancati FL; Folsom AR; Steffes MW
Arch Intern Med; 2005 Sep; 165(16):1910-6. PubMed ID: 16157837
[TBL] [Abstract][Full Text] [Related]
20. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
